ClinicalMetric / Countries / Czech Republic / relapse
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

relapse Clinical Trials in Czech Republic

Active clinical trials for relapse with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT07570407
Recruiting

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Enrollment
75 pts
Country
🇨🇿 Czech Republic
University Hospital Pilsen
View Trial →

Frequently Asked Questions

How many relapse clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for relapse with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a relapse clinical trial in Czech Republic?
To join a relapse clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are relapse trials in Czech Republic?
Active relapse trials in Czech Republic span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global relapse Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology